echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > One belt, one road, and the central and Eastern European pharmaceutical market.

    One belt, one road, and the central and Eastern European pharmaceutical market.

    • Last Update: 2016-05-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: from May 23, 2016, the world pharmaceutical raw materials China Exhibition (CPHI China) will welcome new guests, who are ministers of health and business representatives of China's 16 European countries At the opening ceremony of CPHI China Exhibition on the morning of June 21, ministers of health of central and Eastern European countries will ceremoniously cut ribbon for the exhibition Subsequently, on that day, the China CEE business matchmaking meeting, the second China CEE health ministers' Forum Health Industry Sub forum will be held in the exhibition hall one after another, and this CPHI China exhibition will become a grand event of China CEE bilateral cooperation in medicine and health industry Next, Xiaobian will take you to the pharmaceutical market in central and Eastern Europe China China one belt, one road and 16 countries, has entered the "fast track" with the establishment of China - Central and Eastern European cooperation mechanism One belt, one road to the development of central and Eastern Europe, China and central and Eastern Europe will soon enter a new historical opportunity In 2011, the total volume of bilateral pharmaceutical trade between China and central and Eastern Europe reached 770 million US dollars, increasing to 1.52 billion US dollars by 2015, with an average annual growth rate of more than 20% Among them, Poland, Slovenia and Hungary export to major destinations in central and Eastern Europe, accounting for 57% of exports Table: data source of medical and health products trade between China and central and Eastern European countries in 2011-2015: Statistics and exploration of China Medical Insurance chamber of Commerce in central and Eastern Europe for a long time, the economies of central and Eastern European countries are heavily dependent on the developed countries in Western Europe, the foundation of pharmaceutical industry in some regions is relatively weak, and most pharmaceutical products and medical devices rely on imports After more than ten years of transformation and adjustment, it is now in the stage of economic recovery and stable growth It is estimated that in 2016, the scale of the pharmaceutical market in central and Eastern Europe is about 104.2 billion US dollars, of which Poland is the largest pharmaceutical market in central and Eastern Europe, and 70% of the market share is occupied by generic drugs In comparison, due to the strict cost accounting and reimbursement system, the share of generic drugs in Romanian and Czech pharmaceutical markets is lower, 30% and 40% respectively Although the share of generic drugs varies greatly in central and Eastern European countries, it is still an attractive pharmaceutical market On the one hand, central and Eastern European countries have good location advantages and investment environment The Czech Republic, Slovakia, Poland, Hungary, Slovenia, Estonia, Latvia and Lithuania are all EU member countries Therefore, they are basically compatible with the EU in terms of market access policies, drug quality standards and intellectual property protection, and the cost is lower than that of Western European countries On the other hand, the market of drugs and medical devices in central and Eastern European countries has not reached the saturation level, and the health expenditure in these markets will continue to increase, and the industrial demand will be strong At present, the trade environment of Poland, Bulgaria, Hungary, Czech and other countries is stable, the market demand is growing, the trade with Chinese enterprises is becoming more frequent, and the trade volume is also rising Over the years since the establishment of bilateral trade, domestic enterprises such as Sichuan Jihe, Huahai pharmaceutical and Sinopharm group have close contacts with the market of central and Eastern Europe In general, due to the lack of understanding of Chinese high-quality pharmaceutical enterprises and brands by the central and Eastern European governments and industries, Chinese enterprises have limited knowledge of local laws and regulations and market rules, and the overall scale of trade between China and central and Eastern Europe is relatively small In terms of product categories, in 2015, the products exported to the central and Eastern European markets were mainly western medicine APIs, hospital diagnosis and treatment equipment, disposable consumables and health rehabilitation products, with the export volume of 530 million, 177 million, 100 million and 90 million US dollars, accounting for 81% of the total export volume, of which, the export of Western medicine raw materials became the most exported products to central and Eastern Europe, with the overall proportion as high as 47.8% 。 In addition to traditional trade, China CEE health cooperation has more areas to explore Central and Eastern European countries have the top life science industry and perfect regulatory system in Europe, good infrastructure, perfect network of universities and research institutions, and government support and encouragement, especially in the field of molecular genetics and biotechnology For Chinese pharmaceutical enterprises in transformation and upgrading, they need to introduce a large number of patented products, core technologies and key equipment The cost of technology transfer in central and Eastern European countries has obvious advantages over developed countries such as the United States and the United States The population of central and Eastern European countries generally has a high level of education and quality, and has the advantages of cultural and linguistic communication Although the market scale of central and Eastern Europe is relatively small, it has a good location advantage and investment environment, which has a certain radiation effect on the EU pharmaceutical market It is one of the ways for Chinese enterprises to open the EU market through central and Eastern Europe In addition, there is a large market demand for Chinese herbal medicine in some central and Eastern European countries With the tightening of the EU's export regulatory policy for Chinese patent medicine, it is also possible to jointly promote the entry of Chinese herbal medicine products into the EU market with central and Eastern European countries Medical service trade, which is dominated by medical tourism, is also one of the potential areas of bilateral cooperation in the future Central and Eastern Europe is rich in medical tourism resources For example, there are 15 health spa centers registered in the medical and health sector in Bosnia and Herzegovina They are located in Orovo, voiica, Sarajevo and other places Most of these spa centers need to seek investment and strategic partners for the upgrading and modernization of existing facilities.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.